IL142761A0 - Novel system for regulating transgene expression - Google Patents

Novel system for regulating transgene expression

Info

Publication number
IL142761A0
IL142761A0 IL14276199A IL14276199A IL142761A0 IL 142761 A0 IL142761 A0 IL 142761A0 IL 14276199 A IL14276199 A IL 14276199A IL 14276199 A IL14276199 A IL 14276199A IL 142761 A0 IL142761 A0 IL 142761A0
Authority
IL
Israel
Prior art keywords
nucleic acid
transgene expression
novel system
expression
tta
Prior art date
Application number
IL14276199A
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL142761A0 publication Critical patent/IL142761A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)

Abstract

The invention concerns novel compositions and methods for controlling nucleic acid expression in cells. More particularly, it concerns any nucleic acid characterised in that it comprises: a) a first region comprising a nucleic acid coding for a tetracycline (tTA)-dependent transactivator under the control of a moderate promoter; and b) a second region comprising a nucleic acid of interest under the control of tTA sensitive promoter. The invention is more particularly useful for controlling the expression of nucleic acids in the nerve cells, in vitro as well as in vivo, for example the human tyrosine hydrocyclosis.
IL14276199A 1998-11-09 1999-11-09 Novel system for regulating transgene expression IL142761A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (en) 1998-11-09 1998-11-09 NEW SYSTEM FOR REGULATING EXPRESSION OF A TRANSGEN
US12260099P 1999-03-03 1999-03-03
PCT/FR1999/002752 WO2000028062A1 (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Publications (1)

Publication Number Publication Date
IL142761A0 true IL142761A0 (en) 2002-03-10

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14276199A IL142761A0 (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Country Status (11)

Country Link
EP (1) EP1129204B1 (en)
JP (1) JP4516215B2 (en)
KR (1) KR20020013476A (en)
CN (1) CN1352694A (en)
AT (1) ATE317020T1 (en)
AU (1) AU1165400A (en)
CA (1) CA2351015C (en)
DE (1) DE69929718T2 (en)
HU (1) HUP0104032A3 (en)
IL (1) IL142761A0 (en)
WO (1) WO2000028062A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
US20040234974A1 (en) * 2001-04-09 2004-11-25 Mutsuya Yamamoto Gene expression controlling unit and utilization thereof
CN1453361A (en) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 Construction method of virus as anticancer targeting adjustable gene
RU2012123145A (en) * 2009-11-05 2013-12-10 Проекто Де Биомедисина Сима, С.Л. Gene construct (VARIANTS) AND RECOMBINANT VIRAL VECTOR GENOME BASED THEREON, virion, THEIR PHARMACEUTICAL COMPOSITION, METHOD FOR IN VITRO expression of polynucleotides in cells HEPATIC NATURE medicament METHOD FOR TREATING LIVER DISEASE (VARIANTS) induced BIDIRECTIONAL PROMOTER-OPERATOR
CN102690338A (en) * 2012-05-25 2012-09-26 中国农业大学 Protein TetR combinable with tetracycline and coding genes and applications of protein TetR combinable with tetracycline
CN110358812B (en) * 2019-06-25 2022-12-27 武汉生物工程学院 Primer and detection method for gene knockout and recombination positive clone detection of lambda-Red recombination system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705334A1 (en) * 1993-06-14 1996-04-10 Basf Aktiengesellschaft Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
CA2351015C (en) 2011-09-27
ATE317020T1 (en) 2006-02-15
CA2351015A1 (en) 2000-05-18
EP1129204A1 (en) 2001-09-05
KR20020013476A (en) 2002-02-20
HUP0104032A3 (en) 2003-09-29
DE69929718D1 (en) 2006-04-13
JP2002529099A (en) 2002-09-10
WO2000028062A1 (en) 2000-05-18
EP1129204B1 (en) 2006-02-01
CN1352694A (en) 2002-06-05
AU1165400A (en) 2000-05-29
JP4516215B2 (en) 2010-08-04
HUP0104032A2 (en) 2002-02-28
DE69929718T2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
AU4833897A (en) Glial mitogenic factors, their preparation and use
SG141233A1 (en) Control of gene expression
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
MX9705039A (en) Programmed cell death genes and proteins.
AU2077197A (en) Polypeptides having phytase activity and nucleic acids encoding same
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
MX9702212A (en) Novel pesticidal proteins and strains.
CA2079454A1 (en) Steroid 5.alpha.-reductases
WO1998051663A3 (en) 3-epi compounds of vitamin d3 and uses thereof
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
IL142761A0 (en) Novel system for regulating transgene expression
AU7154096A (en) Blue copper oxidase mutants with enhanced activity
CA2159614A1 (en) Control of plant abscission and pod dehiscence
AU1054699A (en) Cold-inducible expression vector
WO1998040498A3 (en) Immunoadhesins and methods of production and use thereof
AU1896500A (en) High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
HK1038572A1 (en) Growth differentiation factor promoter and uses therefor
AU2634597A (en) Compounds with growth hormone releasing properties
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
AU3382097A (en) Aspergillus oryzae 5-aminolevulinic acid synthases and nucleic acids encoding same
WO1998010085A3 (en) Gene therapy for congestive heart failure
WO2004033653A3 (en) Gene regulation with aptamer and modulator complexes for gene therapy
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
NO924192L (en) BIOSYNTHETIC PROCEDURE FOR THE PREPARATION OF CHEMICAL COMPOUNDS
EP0808364A4 (en) Human pancreatic cell lines: developments and uses